Correlation Between Aptorum Group and Exagen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aptorum Group and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aptorum Group and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aptorum Group Ltd and Exagen Inc, you can compare the effects of market volatilities on Aptorum Group and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aptorum Group with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aptorum Group and Exagen.

Diversification Opportunities for Aptorum Group and Exagen

-0.64
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aptorum and Exagen is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Aptorum Group Ltd and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and Aptorum Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aptorum Group Ltd are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of Aptorum Group i.e., Aptorum Group and Exagen go up and down completely randomly.

Pair Corralation between Aptorum Group and Exagen

Considering the 90-day investment horizon Aptorum Group Ltd is expected to generate 5.49 times more return on investment than Exagen. However, Aptorum Group is 5.49 times more volatile than Exagen Inc. It trades about 0.04 of its potential returns per unit of risk. Exagen Inc is currently generating about 0.03 per unit of risk. If you would invest  540.00  in Aptorum Group Ltd on October 4, 2024 and sell it today you would lose (320.00) from holding Aptorum Group Ltd or give up 59.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Aptorum Group Ltd  vs.  Exagen Inc

 Performance 
       Timeline  
Aptorum Group 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aptorum Group Ltd are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Aptorum Group displayed solid returns over the last few months and may actually be approaching a breakup point.
Exagen Inc 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Exagen Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Exagen displayed solid returns over the last few months and may actually be approaching a breakup point.

Aptorum Group and Exagen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aptorum Group and Exagen

The main advantage of trading using opposite Aptorum Group and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aptorum Group position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.
The idea behind Aptorum Group Ltd and Exagen Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets